Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patientsMasaki Shiota, Atsushi Takahashi, Takahiro Kimura et al.|Cancer Science|2020Cited by 48
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancerNaoki Terada, Takashi Mizowaki, Toshihiro Saito et al.|BJUI Compass|2020Cited by 19
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura et al.|Cancer Science|2021Cited by 15
The G7 presidency and universal health coverage, Japan’s contributionHaruka Sakamoto, Kenji Shibuya, Satoshi Ezoe et al.|Bulletin of the World Health Organization|2018Cited by 5
Japan’s contribution to making global health architecture a top political agenda by leveraging the G7 presidencyHaruka Sakamoto, Kenji Shibuya, Satoshi Ezoe et al.|Journal of Global Health|2018Cited by 4